2004
DOI: 10.1111/j.1751-1097.2004.tb00086.x
|View full text |Cite
|
Sign up to set email alerts
|

Photoinactivation of Hepatitis A Virus by Synthetic Porphyrins

Abstract: Porphyrins are photosensitizers and may be applicable in situations where viral inactivation is required, as for in vitro inactivation of nonenveloped viruses in blood components or in other aqueous media. No study has examined the efficacy of porphyrin inactivation on human pathogens such as hepatitis A virus (HAV) in plasma or other liquids. Experiments were conducted to evaluate the effect of synthetic porphyrins on HAV in porphyrin‐containing human plasma and phosphatebuffered saline exposed to long‐wavele… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0
3

Year Published

2012
2012
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 21 publications
(12 citation statements)
references
References 50 publications
0
9
0
3
Order By: Relevance
“…The first report of antiviral PACT using cationic meso-tetrakis (N-methyl-4-pyridiniumyl) porphyrin (TMPyP4) and anionic tetrakis (4-sulfonatophenil) porphyrin (TPPS4) showed an efficient inactivation of non-enveloped MS2 bacteriophage and HAV in PBS solution and plasma. Importantly, none of these compounds were mutagenic, and the activity of cationic compound was much better with regards to the time of light exposure required to achieve significant virus inactivation, and also its activity in the absence light (Casteel et al 2004). The efficiency of TMPyP4 encouraged efforts to develop more effective cationic amphiphilic PS with increased lipophilicity, such as amphiphilic meso-alkylated tetrakis (N-(n-octly)-4-pyridiniumyl) porphyrin (TOcPyP4) and tetrakis (N-(nbutyl)-4-pyridiniumyl) porphyrin (TBuPyP4) and tetrakis (N-(n-hexadecyl)-4-pyridiniumyl) porphyrin (THdPyP4), which showed similar activity against HAV and MS2.…”
Section: Antiviral Pact and Porphyrin-based Cationic Amphiphilic Pssmentioning
confidence: 99%
See 1 more Smart Citation
“…The first report of antiviral PACT using cationic meso-tetrakis (N-methyl-4-pyridiniumyl) porphyrin (TMPyP4) and anionic tetrakis (4-sulfonatophenil) porphyrin (TPPS4) showed an efficient inactivation of non-enveloped MS2 bacteriophage and HAV in PBS solution and plasma. Importantly, none of these compounds were mutagenic, and the activity of cationic compound was much better with regards to the time of light exposure required to achieve significant virus inactivation, and also its activity in the absence light (Casteel et al 2004). The efficiency of TMPyP4 encouraged efforts to develop more effective cationic amphiphilic PS with increased lipophilicity, such as amphiphilic meso-alkylated tetrakis (N-(n-octly)-4-pyridiniumyl) porphyrin (TOcPyP4) and tetrakis (N-(nbutyl)-4-pyridiniumyl) porphyrin (TBuPyP4) and tetrakis (N-(n-hexadecyl)-4-pyridiniumyl) porphyrin (THdPyP4), which showed similar activity against HAV and MS2.…”
Section: Antiviral Pact and Porphyrin-based Cationic Amphiphilic Pssmentioning
confidence: 99%
“…The efficiency of TMPyP4 encouraged efforts to develop more effective cationic amphiphilic PS with increased lipophilicity, such as amphiphilic meso-alkylated tetrakis (N-(n-octly)-4-pyridiniumyl) porphyrin (TOcPyP4) and tetrakis (N-(nbutyl)-4-pyridiniumyl) porphyrin (TBuPyP4) and tetrakis (N-(n-hexadecyl)-4-pyridiniumyl) porphyrin (THdPyP4), which showed similar activity against HAV and MS2. Photodynamic activity of such PS was, to a certain degree, less efficient in plasma than PBS, which can be explained by affinity to albumin and other plasma proteins that increases with an increase in hydrophobicity of the porphyrin side chain (Casteel et al 2004). Similar to the case for pthalocyanines, the molecular mechanism by which cationic porphyrines inhibit viruses has not received sufficient attention.…”
Section: Antiviral Pact and Porphyrin-based Cationic Amphiphilic Pssmentioning
confidence: 99%
“…Desinfecção por fotoinativação por porrinas sintéticas, portanto, pode oferecer uma abordagem ecaz e relativamente segura para remoção de vírus não envelopados de meios aquosos (CASTEEL et al, 2004).…”
Section: Fotoinativação Viralunclassified
“…O primeiro estudo para examinar a ecácia de porrinas na fotoinativação de patógenos humanos, tais como o vírus da hepatite A (HAV) no plasma e outros líquidos, foi realizado por Casteel et al (2004). O efeito de porrinas sintéticas sobre o HAV e o bacteriófago MS2 em plasma humano foi observado: ocorreu 99,9% de inativação em ambos, HAV e MS2, mostrando que o método pode ser uma abordagem efetiva e segura de remoção de vírus não envelopados em meios aquosos (CASTEEL et al, 2004).…”
Section: Utilização Atual Da Fotoinativação Em Micro-organismosunclassified
See 1 more Smart Citation